Research location
Venray
Netherlands
Advertisement
Research activity in Venray
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Venray
9 linked trials · page 1 of 1Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With ExemestaneNCT02109913 · 2014-03-01 · 1 site observation
UNKNOWN
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple SclerosisNCT01457924 · 2011-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical AntipsychoticsNCT00689325 · 2008-04-01 · 1 site observation
COMPLETED
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)NCT00533260 · 2007-07-01 · 1 site observation
COMPLETED
Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation
COMPLETED
Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)NCT00395317 · 2006-12-01 · 1 site observation
COMPLETED
Arimidex Observational: Reason for and Effect of Change From TamoxifenNCT00246961 · 2004-07-01 · 1 site observation
COMPLETED
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European GuidelinesNCT00233649 · 2004-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.